Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-25-020218

Co-CEO and CFO acquired 3,598 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Martin James Joseph Co-CEO and CFO 2025-10-28 Grant or award +3,598 $1.39 $5,001 44,167 D
Derivatives
Martin James Joseph Co-CEO and CFO 2025-10-28 Grant or award · Warrants +7,196 $1.39 $10,002 7,196 D
Loading xslF345X05/ownership.xml…